Background Carcinoembryonic antigen is the commonly used tumor marker in patients with
colorectal cancer, and CA 19-9 might be an additional marker. The aim of this retrospective …

Aim. The aim of this study is to determine the significance of postoperative sequential
measurements of serum CA19-9 in patients with extremely low serum level. Patients and …

Purpose Carcinoembrionic Antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) are the
most frequently used tumor markers in the clinical setting of colorectal cancer. The aim of …

Background The serum carcinoembryonic antigen (CEA) test is mainly used for
postoperative surveillance of colorectal cancer patients in Western and Japanese …

Purpose The purpose of this study is to evaluate the prognostic value of preoperative serum
CA 19-9 levels in colorectal cancer patients. Methods Between 2008 and 2011, 4,794 …

Purpose Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) are the
most frequently used tumor markers in the clinical setting of colorectal cancer (CRC). This …

The objective of the study was to compare the clinical value of preoperative serum
carbohydrate antigen 19-9 (CA19-9) and carbohydrate antigen 242 (CA242) in diagnosis …

Background In colorectal cancer (CRC) patients, guidelines only recommend measurement
of preoperative carcinoembryonic antigen (CEA), although postoperative CEA may be more …

Background/Aim: To evaluate whether the serum levels of CEA or CA19-9 concentration is a
useful predictor of survival in patients with metastatic colon cancer (mCC). Patients and …

Background: Many risk factors for recurrence in stage II colorectal cancer (CRC) have been
proposed, and the efficacy of adjuvant chemotherapy is still controversial. This study aimed …